Key terms
About LAB
Standard BioTools Inc. engages in the provision of biotechnology tools and services for clinical research. It sells preparatory and analytical instruments for mass cytometry, polymerase chain reaction, library prep, single cell genomics, and consumables including integrated fluidic circuits (IFCs), assays, and reagents. The company was founded by Stephen D. Quake and Gajus Vincent Worthington on May 19, 1999 and is headquartered in South San Francisco, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest LAB news
Apr 16
6:43am ET
TD Cowen starts Standard BioTools at Buy, sees ‘a lot to like’
Apr 16
5:43am ET
Standard BioTools initiated with a Buy at TD Cowen
Apr 08
8:07am ET
Standard BioTools announces new solutions for Imaging Mass Cytometry workflow
Apr 04
8:10am ET
Analysts Offer Insights on Healthcare Companies: Bausch Health Companies (BHC) and Standard BioTools (LAB)
Apr 04
5:06am ET
Standard BioTools initiated with a Buy at Jefferies
Apr 03
4:03pm ET
Standard BioTools announces multi-year agreement with Bristol Myers
Mar 18
9:22am ET
Standard BioTools Streamlines Structure and Strengthens Governance
Mar 18
8:19am ET
Standard BioTools announces exchange of all oustanding Series B Preferred stock
Feb 28
4:25pm ET
Standard BioTools Projects Positive Outlook for 2024
Feb 26
8:11am ET
Standard BioTools, NGD partner for automation of pathogen sequencing
Feb 07
8:31am ET
Standard BioTools, Navignostics announce collaboration agreement
Jan 19
5:09pm ET
Standard BioTools files to sell 38.43M shares of common stock for holders
No recent press releases are available for LAB
LAB Financials
Key terms
Ad Feedback
LAB Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
LAB Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
